Table 1.
Cell adhesion family | Gene symbol | Gene name | Fold change (±S.D.)
|
|||
---|---|---|---|---|---|---|
CPu | NAc | PFC | Amy | |||
Neurexin | Nrxn1a | Neurexin1 | 0.79±0.27 | 1.42±1.15 | 0.94±0.27 | 0.84±0.35 |
Nrxn2 | Neurexin2 | 0.76±0.11 | 0.78±0.11 | 0.72±0.20 | 0.99±0.65 | |
Nrxn3a | Neurexin3 | 0.62±0.25 | 1.12±0.83 | 0.75±0.02* | 0.84±0.23 | |
Nlgn1 | Neuroligin1 | 0.60±0.16* | 1.25±0.84 | 0.84±0.08 | 0.86±0.21 | |
Immunoglobulin | Ncam1 | Neural cell adhesion molecule 1 | 0.84±0.32 | 0.93±0.14 | 0.96±0.05 | 0.47±0.05** |
Cntn4a | Contactin 4 | 0.45±0.01*** | 0.67±0.01 | 0.66±0.04** | 1.20±0.23 | |
Cntn5a | Contactin 5 | 0.72±0.07* | 1.20±0.96 | 0.82±0.67 | 1.06±0.79 | |
Cntn6a | Contactin 6 | 0.66±0.15* | 1.13±0.30 | 0.74±0.16 | 1.12±0.99 | |
Dscama | Down syndrome cell adhesion molecule | 0.66±0.17* | 1.46±0.08 | 0.66±0.12* | 0.95±0.43 | |
Pecam1 | Platelet/endothelial cell adhesion molecule 1 | 0.97±0.45 | 0.94±0.21 | 1.32±0.52 | 0.59±0.03* | |
Integrin | Itgb1 | Integrin beta 1 | 0.97±0.25 | 1.28±0.49 | 0.99±0.25 | 1.12±1.00 |
Postn | Periostin, osteoblast specific factor | 0.65±0.03*** | 1.40±0.11* | 1.58±0.42* | 1.00±0.70 | |
Vclb | Vinculin | 0.74±0.28 | 0.72±0.30 | 1.09±0.03 | 1.22±0.71 | |
Actn1b | Actinin, alpha 1 | 0.46±0.13* | 0.69±0.27 | 0.95±0.18 | 0.93±0.40 | |
Zyxb | Zyxin | 0.54±0.62 | 1.09±0.24 | 0.61±0.01 | 0.80±0.07 | |
Cadherin | Cdh13a | Cadherin 13 | 0.51±0.21* | 0.74±0.11 | 0.94±0.06 | 1.02±0.68 |
Pcdh9a | Protocadherin 9 | 0.89±0.07 | 0.83±0.17 | 1.15±0.07 | 0.86±0.13 | |
Ctnna1b | Catenin (cadherin associated protein), alpha 1 | 0.63±0.07** | 1.17±0.42 | 0.73±0.21 | 0.87±0.31 | |
Ctnna2b | Catenin (cadherin associated protein), alpha 2 | 0.67±0.03*** | 1.22±0.16 | 0.85±0.13 | 1.10±0.92 | |
Ctnna3b | Catenin (cadherin associated protein), alpha 3 | 0.67±0.20 | 1.32±0.54 | 0.67±0.90 | 1.37±0.56 | |
Ctnnb1b | Catenin (cadherin associated protein), beta 1 | 0.71±0.05** | 1.08±0.33 | 0.76±0.12 | 1.03±0.65 | |
Ctnnd2ab | Catenin (cadherin-associated protein), delta 2 | 0.61±0.09** | 1.28±0.13 | 0.67±0.18 | 0.95±0.44 | |
Vclb | Vinculin | 0.74±0.28 | 0.72±0.30 | 1.09±0.03 | 1.22±0.71 | |
Actn1b | Actinin, alpha 1 | 0.46±0.13* | 0.69±0.27 | 0.95±0.18 | 0.93±0.40 | |
Fynb | Fyn proto-oncogene | 0.62±0.10** | 1.13±0.36 | 0.89±0.12 | 0.96±0.82 | |
Adhesion GPCR | Bai3a | Brain-specific angiogenesis inhibitor 3 | 0.59±0.16* | 0.74±0.27 | 0.96±0.11 | 0.94±0.32 |
Lphn3a | Latrophilin 3 | 0.66±0.18* | 1.08±0.56 | 1.06±0.17 | 0.62±0.02* | |
Others | Lrrn1a | Leucine rich repeat neuronal 1 | 0.75±0.18 | 1.33±0.69 | 1.10±0.32 | 0.91±0.25 |
Ptprda | Receptor-type protein tyrosine phosphatase D | 0.30±0.37 | 0.57±0.11* | 1.69±0.82 | 0.79±0.14 | |
Csmd1a | CUB and Sushi multiple domains 1 | 0.66±0.04*** | 1.13±0.33 | 0.54±0.05 | 0.96±0.03 | |
Sgcza | Sarcoglycan zeta | 0.69±0.03 | 0.99±0.17 | 1.46±0.47 | 0.65±0.05** |
CPu, Caudate putamen; NAc, nucleus accumbens; PFC, prefrontal cortex; Amy, amygdala. GPCR, G protein coupled receptor. Cell adhesion molecules and intracellular anchor proteins were modified by gestational nicotine exposure (GN). Fold change >1 indicates up-regulation of gene expression, whereas fold change <1 indicates down-regulation by GN. Data are from qRT–PCR array.
Genes suggested as being associated with drug addiction in human studies.
Genes encode intracellular proteins anchoring cell adhesion molecules.
p<0.05,
p<0.01,
p<0.001 significant difference between GN and control animals.